Cargando…

The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies

Breast cancer (BC) is the most frequently diagnosed malignant tumor among women in the world. BC is the heterogeneous tumor with different subtypes including luminal A-like, luminal B-like (HER2-/HER2+), HER2 enriched, and triple-negative BC. The therapeutic strategies including surgery, chemotherap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Fan, He, Qingjie, Dai, Xiangpeng, Zhang, Xiaoling, Song, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992554/ https://www.ncbi.nlm.nih.gov/pubmed/36909177 http://dx.doi.org/10.3389/fphar.2023.1143102

Ejemplares similares

Overcoming Obstacles to Drug Repositioning in Japan
por: Nishimura, Yuhei, et al.
Publicado: (2017)

Nanomedicine-Mediated Therapies to Target Breast Cancer Stem Cells
por: He, Lili, et al.
Publicado: (2016)

Functional Nanomedicines for Targeted Therapy of Bladder Cancer
por: Tang, Chao, et al.
Publicado: (2021)

Deciphering the role of DOCK8 in tumorigenesis by regulating immunity and the application of nanotechnology in DOCK8 deficiency therapy
por: Zhang, Longhui, et al.
Publicado: (2022)

Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions
por: Gad, Mohamed, et al.
Publicado: (2020)

Overcoming the obstacles of current photodynamic therapy in tumors using nanoparticles
por: Lee, Donghyun, et al.
Publicado: (2021)

Overcoming Obstacles
por: Braile, Domingo M.
Publicado: (2015)

Pharmacologic therapies of ARDS: From natural herb to nanomedicine
por: Meng, Linlin, et al.
Publicado: (2022)

Ferroptosis-Inducing Nanomedicine for Cancer Therapy
por: Wang, Yang, et al.
Publicado: (2021)

Probing the biological obstacles of nanomedicine with gold nanoparticles
por: Li, Bin, et al.
Publicado: (2018)

Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance
por: Greene, Michelle K., et al.
Publicado: (2021)

Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles
por: Wong, Han Hsi, et al.
Publicado: (2010)

Editorial: Advances on targeted nanomedicines for atherosclerosis
por: Han, Qinggong, et al.
Publicado: (2022)

The Potential of Chitosan in Nanomedicine: An Overview of the Cytotoxicity of Chitosan Based Nanoparticles
por: Frigaard, Julie, et al.
Publicado: (2022)

Editorial: Women in nanomedicine
por: Chuah, Lay-Hong, et al.
Publicado: (2023)

Editorial: Novel approaches aiming to overcome current nanomedicine limitations
por: Palomba, Roberto, et al.
Publicado: (2023)

Nanomedicines for Overcoming Cancer Drug Resistance
por: Hu, Tingting, et al.
Publicado: (2022)

Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
por: Hua, Susan, et al.
Publicado: (2018)

Advances in natural compound-based nanomedicine and the interaction with gut microbiota in ulcerative colitis therapy
por: Zhang, Jinlan, et al.
Publicado: (2023)

Macrophage-targeted nanomedicine for the diagnosis and management of atherosclerosis
por: Hu, Ping Ping, et al.
Publicado: (2022)

Discovery of Selenocysteine as a Potential Nanomedicine Promotes Cartilage Regeneration With Enhanced Immune Response by Text Mining and Biomedical Databases
por: Ye, Jing, et al.
Publicado: (2020)

Editorial: Advances and Challenges in Nanomedicine
por: Hua, Susan, et al.
Publicado: (2018)

Activation of cancer immunotherapy by nanomedicine
por: Wang, Lijuan, et al.
Publicado: (2022)

Intracellular Reduction-Responsive Molecular Targeted Nanomedicine for Hepatocellular Carcinoma Therapy
por: Ding, Lei, et al.
Publicado: (2022)

A GSH/CB Dual-Controlled Self-Assembled Nanomedicine for High-Efficacy Doxorubicin-Resistant Breast Cancer Therapy
por: Yang, Yang, et al.
Publicado: (2022)

Advanced targeted nanomedicines for vulnerable atherosclerosis plaque imaging and their potential clinical implications
por: Li, Xue, et al.
Publicado: (2022)

Commentary: A GSH/CB dual-controlled self-assembled nanomedicine for high-efficacy doxorubicin-resistant breast cancer therapy
por: Tian, Tian
Publicado: (2022)

Two-Dimensional Nanosheet-Based Photonic Nanomedicine for Combined Gene and Photothermal Therapy
por: Kim, Na Yoon, et al.
Publicado: (2020)

Application Perspectives of Nanomedicine in Cancer Treatment
por: Hou, Shanshan, et al.
Publicado: (2022)

Overcoming obstacles to repurposing for neurodegenerative disease
por: Shineman, Diana W, et al.
Publicado: (2014)

Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas
por: Wang, Chun, et al.
Publicado: (2023)

Overcoming Vascular Barriers to Improve the Theranostic Outcomes of Nanomedicines
por: Tang, Yufu, et al.
Publicado: (2022)

Editorial: Translating nanomedicines for anti-cancer treatment
por: Siram, Karthik, et al.
Publicado: (2023)

Layered Double Hydroxide Nanomaterials Encapsulating Angelica gigas Nakai Extract for Potential Anticancer Nanomedicine
por: Kim, Hyoung-Jun, et al.
Publicado: (2018)

Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer
por: Navarro-Ocón, Alba, et al.
Publicado: (2022)

Chimeric Antigen Receptor Cell Therapy: Overcoming Obstacles to Battle Cancer
por: Petty, Amy J., et al.
Publicado: (2020)

Sperm DNA fragmentation: overcoming standardization obstacles
por: Majzoub, Ahmad, et al.
Publicado: (2017)

Modulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery
por: Zhang, Bo, et al.
Publicado: (2017)

Editorial: Nanomedicine in Infectious Diseases: Drug Delivery and Vaccines
por: Marepally, Srujan, et al.
Publicado: (2022)

A Current Perspective on the Potential of Nanomedicine for Anti-Tuberculosis Therapy
por: Borah Slater, Khushboo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v99dqacolphb9ql6upd1cnq99l